Cite
HARVARD Citation
Nishio, M. et al. (2020). Ramucirumab or placebo plus erlotinib in EGFR‐mutated, metastatic non‐small‐cell lung cancer: East Asian subset of RELAY. Cancer science. 111 (12), pp. 4510-4525. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nishio, M. et al. (2020). Ramucirumab or placebo plus erlotinib in EGFR‐mutated, metastatic non‐small‐cell lung cancer: East Asian subset of RELAY. Cancer science. 111 (12), pp. 4510-4525. [Online].